Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Vox Sanguinis
|
September 28, 2020
Development of an updated assay for prekallikrein activator in albumin and immunoglobulin therapeutics
Graham Roberts, Bernard Fox, Colin Longstaff
Transfusion Medicine (Oxford, England)
|
November 27, 2019
The British Standard for (European Conformity[CE] Marked) Anti-D: Its rarely discussed but important role in quantitating anti-D in patient plasma
Bernard Fox, Jason Hockley, Lucy Studholme
Biologicals : Journal of the International Association of Biological Standardization
|
November 8, 2002
A stable lyophilized reagent for use in a potential reference assay for quantitation of anti-D in immunoglobulin products
Susan J Thorpe, Bernard Fox, Dawn Sands
Clinical Chemistry and Laboratory Medicine
|
December 23, 2021
International collaborative study to evaluate and calibrate two recombinant L chain Ferritin preparations for use as a WHO International Standard
Bernard Fox, Graham Roberts, Eleanor Atkinson, et al.
Vox Sanguinis
|
October 26, 2021
Evaluation of prophylactic polyclonal anti-D antibodies: Differences in Fc-glycosylation in commercial products
Filippo Mori, Alfonso Salvatore, Ester Ascione, et al.
Clinical Chemistry and Laboratory Medicine
|
May 9, 2014
The 3rd International Standard for serum IgE: international collaborative study to evaluate a candidate preparation
Susan J Thorpe, Alan Heath, Bernard Fox, et al.
Vox Sanguinis
|
July 20, 2019
The third international standard for anti-D immunoglobulin: international collaborative study to evaluate candidate preparations
Bernard Fox, Giles Sharp, Eleanor Atkinson, et al.
Mabs
|
October 7, 2017
International standards for monoclonal antibodies to support pre- and post-marketing product consistency: Evaluation of a candidate international standard for the bioactivities of rituximab
Sandra Prior, Simon E Hufton, Bernard Fox, et al.
Transfusion
|
March 19, 2008
Anti-D and anti-i activities are inseparable in V4-34-encoded monoclonal anti-D: the same framework 1 residues are required for both reactivities
Susan J Thorpe, Christine Ball, Bernard Fox, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
July 24, 2021
A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation
Michele Maio, Michael Lahn, Anna Maria Di Giacomo, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Vox Sanguinis
|
September 28, 2020
Development of an updated assay for prekallikrein activator in albumin and immunoglobulin therapeutics
Graham Roberts, Bernard Fox, Colin Longstaff
Transfusion Medicine (Oxford, England)
|
November 27, 2019
The British Standard for (European Conformity[CE] Marked) Anti-D: Its rarely discussed but important role in quantitating anti-D in patient plasma
Bernard Fox, Jason Hockley, Lucy Studholme
Biologicals : Journal of the International Association of Biological Standardization
|
November 8, 2002
A stable lyophilized reagent for use in a potential reference assay for quantitation of anti-D in immunoglobulin products
Susan J Thorpe, Bernard Fox, Dawn Sands
Clinical Chemistry and Laboratory Medicine
|
December 23, 2021
International collaborative study to evaluate and calibrate two recombinant L chain Ferritin preparations for use as a WHO International Standard
Bernard Fox, Graham Roberts, Eleanor Atkinson, et al.
Vox Sanguinis
|
October 26, 2021
Evaluation of prophylactic polyclonal anti-D antibodies: Differences in Fc-glycosylation in commercial products
Filippo Mori, Alfonso Salvatore, Ester Ascione, et al.
Clinical Chemistry and Laboratory Medicine
|
May 9, 2014
The 3rd International Standard for serum IgE: international collaborative study to evaluate a candidate preparation
Susan J Thorpe, Alan Heath, Bernard Fox, et al.
Vox Sanguinis
|
July 20, 2019
The third international standard for anti-D immunoglobulin: international collaborative study to evaluate candidate preparations
Bernard Fox, Giles Sharp, Eleanor Atkinson, et al.
Mabs
|
October 7, 2017
International standards for monoclonal antibodies to support pre- and post-marketing product consistency: Evaluation of a candidate international standard for the bioactivities of rituximab
Sandra Prior, Simon E Hufton, Bernard Fox, et al.
Transfusion
|
March 19, 2008
Anti-D and anti-i activities are inseparable in V4-34-encoded monoclonal anti-D: the same framework 1 residues are required for both reactivities
Susan J Thorpe, Christine Ball, Bernard Fox, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
July 24, 2021
A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation
Michele Maio, Michael Lahn, Anna Maria Di Giacomo, et al.
Page
of 3